IBM
53
2
FITB
36
3
OXY
42
17
MAT
41
2
FTI
61
5
HIG
48
5
TROW
37
8
ECL
54
5
SYK
50
4
EW
55
5
BEN
36
4
MHK
25
5
CINF
24
-8
EQT
47
13
PFG
27
7
HSIC
42
2
LEN
21
3
GM
55
6
SJM
17
5
PM
49
8
IBM
53
2
FITB
36
3
OXY
42
17
MAT
41
2
FTI
61
5
HIG
48
5
TROW
37
8
ECL
54
5
SYK
50
4
EW
55
5
BEN
36
4
MHK
25
5
CINF
24
-8
EQT
47
13
PFG
27
7
HSIC
42
2
LEN
21
3
GM
55
6
SJM
17
5
PM
49
8
Financhill
Back

Royalty Pharma PLC Vs. Arbutus Biopharma Industry Stock Comparison

Sell
32

RPRX
Royalty Pharma PLC

Last Price:
$24.97
Seasonality Move:
1.44%
Sell
27

ABUS
Arbutus Biopharma

Last Price:
$3.20
Seasonality Move:
21.65%
Sell
32
Royalty Pharma PLC (RPRX) is a Sell

Is Royalty Pharma PLC a Buy, Sell or Hold?

  • The current Royalty Pharma PLC [RPRX] share price is $24.94. The Score for RPRX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • RPRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.21. The Score for ABUS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RPRX Stock Price Chart

What is Royalty Pharma PLC's stock price today?

  • The Royalty Pharma PLC share price today is $24.94
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing slight buying pressure.

RPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 39.23 Sell
Chaikin Money Flow: 5676845 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.09 - 26.47) Sell
Bollinger Bands (100): (26.05 - 28.27) Sell

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 33.79 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.35 - 3.65) Sell
Bollinger Bands (100): (3.53 - 4.11) Sell

RPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.88 Buy
20-day SMA: 25.71 Sell
50-day SMA: 26.45 Sell
200-day SMA: 27.59 Sell
8-day EMA: 24.95 Sell
20-day EMA: 25.48 Sell
50-day EMA: 26.23 Sell
200-day EMA: 27.55 Sell

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.41 Sell
20-day SMA: 3.5 Sell
50-day SMA: 3.71 Sell
200-day SMA: 3.44 Sell
8-day EMA: 3.37 Sell
20-day EMA: 3.49 Sell
50-day EMA: 3.63 Sell
200-day EMA: 3.44 Sell

Royalty Pharma PLC Earnings Growth & RPRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.24 per share, and an increase next year of $0.22 per share.

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

Royalty Pharma PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):